{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:33:05Z","timestamp":1781839985824,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00066-019-01538-2","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T13:02:46Z","timestamp":1573822966000},"page":"117-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients"],"prefix":"10.1007","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9303-7336","authenticated-orcid":false,"given":"Khaled","family":"Elsayad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Reinartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Rehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Eismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Scobioala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Berssenbr\u00fcgge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Eter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut H.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte","family":"Friedrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Gr\u00fcnewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Wardelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normann","family":"Willich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"issue":"1","key":"1538_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","volume":"92","author":"J Yahalom","year":"2015","unstructured":"Yahalom\u00a0J, Illidge\u00a0T, Specht\u00a0L et\u00a0al (2015) Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92(1):11\u201331. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"1538_CR2","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1182\/blood-2018-08-822148","volume":"133","author":"C Casulo","year":"2019","unstructured":"Casulo\u00a0C, Barr\u00a0PM (2019) How I treat early-relapsing follicular lymphoma. Blood 133(14):1540\u20131547. https:\/\/doi.org\/10.1182\/blood-2018-08-822148","journal-title":"Blood"},{"key":"1538_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-319-42615-0_4","volume-title":"Radiation therapy in hematologic malignancies","author":"U Ricardi","year":"2017","unstructured":"Ricardi\u00a0U, Filippi\u00a0AR, Piva\u00a0C et\u00a0al (2017) Extranodal marginal zone lymphoma. In: Dabaja\u00a0BS, Ng\u00a0AK (eds) Radiation therapy in hematologic malignancies, vol 24. Springer, Cham, pp\u00a055\u201371"},{"issue":"1","key":"1538_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bjh.12730","volume":"165","author":"MO Khalil","year":"2014","unstructured":"Khalil\u00a0MO, Morton\u00a0LM, Devesa\u00a0SS et\u00a0al (2014) Incidence of marginal zone lymphoma in the United States, 2001\u20132009 with a\u00a0focus on primary anatomic site. Br J Haematol 165(1):67\u201377. https:\/\/doi.org\/10.1111\/bjh.12730","journal-title":"Br J Haematol"},{"issue":"16","key":"1538_CR5","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1002\/cncr.25226","volume":"116","author":"JS Goda","year":"2010","unstructured":"Goda\u00a0JS, Gospodarowicz\u00a0M, Pintilie\u00a0M et al (2010) Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 116(16):3815\u20133824. https:\/\/doi.org\/10.1002\/cncr.25226","journal-title":"Cancer"},{"issue":"3","key":"1538_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1182\/blood-2016-05-714584","volume":"129","author":"A Desai","year":"2017","unstructured":"Desai\u00a0A, Joag\u00a0MG, Lekakis\u00a0L et al (2017) Long-term course of patients with primary ocular adnexal MALT lymphoma: a\u00a0large single-institution cohort study. Blood 129(3):324\u2013332. https:\/\/doi.org\/10.1182\/blood-2016-05-714584","journal-title":"Blood"},{"issue":"2","key":"1538_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4143\/crt.2017.182","volume":"50","author":"G-I Lee","year":"2018","unstructured":"Lee\u00a0G\u2011I, Oh\u00a0D, Kim\u00a0WS et al (2018) Low-dose radiation therapy for primary conjunctival marginal zone B\u2011cell lymphoma. Cancer Res Treat 50(2):575\u2013581. https:\/\/doi.org\/10.4143\/crt.2017.182","journal-title":"Cancer Res Treat"},{"key":"1538_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-319-42615-0_3","volume-title":"Radiation therapy in hematologic malignancies","author":"B Hoppe","year":"2017","unstructured":"Hoppe\u00a0B (2017) Follicular Lymphoma: treatment for early-stage, grades 1 and 2, and advanced-stage disease. In: Dabaja\u00a0BS, Ng\u00a0AK (eds) Radiation therapy in hematologic malignancies, vol 64. Springer, Cham, pp 45\u201353"},{"issue":"1","key":"1538_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","volume":"74","author":"KJ Neelis","year":"2009","unstructured":"Neelis\u00a0KJ, Schimmel\u00a0EC, Vermeer\u00a0MH et al (2009) Low-dose palliative radiotherapy for cutaneous B\u2011 and T\u2011cell lymphomas. Int J Radiat Oncol Biol Phys 74(1):154\u2013158. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.06.1918","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1538_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/10428194.2015.1040012","volume":"57","author":"M Akhtari","year":"2016","unstructured":"Akhtari\u00a0M, Reddy\u00a0JP, Pinnix\u00a0CC et al (2016) Primary cutaneous B\u2011cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leuk Lymphoma 57(1):34\u201338. https:\/\/doi.org\/10.3109\/10428194.2015.1040012","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"1538_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ijrobp.2013.04.035","volume":"86","author":"CE Fasola","year":"2013","unstructured":"Fasola\u00a0CE, Jones\u00a0JC, Huang\u00a0DD et al (2013) Low-dose radiation therapy (2\u202fGy \u00d7 2) in the treatment of orbital lymphoma. Int J Radiat Oncol Biol Phys 86(5):930\u2013935. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.04.035","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1538_CR12","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/S0360-3016(02)03050-X","volume":"54","author":"J Johannsson","year":"2002","unstructured":"Johannsson\u00a0J, Specht\u00a0L, Mejer\u00a0J et al (2002) Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukemia. Int J Radiat Oncol Biol Phys 54(5):1466\u20131470","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1538_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jaad.2017.07.053","volume":"78","author":"A Goyal","year":"2018","unstructured":"Goyal\u00a0A, Carter\u00a0JB, Pashtan\u00a0I et al (2018) Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B\u2011cell lymphomas: a retrospective study. J\u00a0Am Acad Dermatol 78(2):408\u2013410. https:\/\/doi.org\/10.1016\/j.jaad.2017.07.053","journal-title":"J Am Acad Dermatol"},{"key":"1538_CR14","volume-title":"TNM classification of malignant tumours","year":"2017","unstructured":"Brierley\u00a0J, Gospodarowicz\u00a0MK, Wittekind\u00a0C (eds) (2017) TNM classification of malignant tumours, 8th\u00a0edn. John Wiley & Sons Inc, Chichester, West Sussex, UK, Hoboken, NJ","edition":"8"},{"key":"1538_CR15","first-page":"1","volume-title":"Radiation oncology","author":"HT Eich","year":"2017","unstructured":"Eich\u00a0HT, Elsayad\u00a0K (2017) Radiation therapy in peripheral T\u2011cell and cutaneous lymphomas. In: Wenz\u00a0F (ed) Radiation oncology, vol 57. Springer, Cham, pp 1\u201314"},{"issue":"1","key":"1538_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","volume":"100","author":"L Lowry","year":"2011","unstructured":"Lowry\u00a0L, Smith\u00a0P, Qian\u00a0W et al (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a\u00a0randomised phase III trial. Radiother Oncol 100(1):86\u201392. https:\/\/doi.org\/10.1016\/j.radonc.2011.05.013","journal-title":"Radiother Oncol"},{"issue":"4","key":"1538_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","volume":"15","author":"PJ Hoskin","year":"2014","unstructured":"Hoskin\u00a0PJ, Kirkwood\u00a0AA, Popova\u00a0B et al (2014) 4\u202fGy versus 24\u202fGy radiotherapy for patients with indolent lymphoma (FORT): a\u00a0randomised phase 3 non-inferiority trial. Lancet Oncol 15(4):457\u2013463. https:\/\/doi.org\/10.1016\/S1470-2045(14)70036-1","journal-title":"Lancet Oncol"},{"issue":"1","key":"1538_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2015.01.040","volume":"92","author":"S Teckie","year":"2015","unstructured":"Teckie\u00a0S, Qi\u00a0S, Lovie\u00a0S et al (2015) Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent. Int J Radiat Oncol Biol Phys 92(1):130\u2013137. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1538_CR19","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00066-018-1277-3","volume":"194","author":"L K\u00f6nig","year":"2018","unstructured":"K\u00f6nig\u00a0L, H\u00f6rner-Rieber\u00a0J, Bernhardt\u00a0D et al (2018) Response rates and recurrence patterns after low-dose radiotherapy with 4\u202fGy in patients with low-grade lymphomas. Strahlenther Onkol 194(5):454\u2013461. https:\/\/doi.org\/10.1007\/s00066-018-1277-3","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1538_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","volume":"89","author":"T Illidge","year":"2014","unstructured":"Illidge\u00a0T, Specht\u00a0L, Yahalom\u00a0J et al (2014) Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 89(1):49\u201358. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.01.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1538_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-019-01446-5","author":"G Reinartz","year":"2019","unstructured":"Reinartz\u00a0G, Pyra\u00a0RP, Lenz\u00a0G et\u00a0al (2019) Favorable radiation field decrease in gastric marginal zone lymphoma: Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL). Strahlenther Onkol. https:\/\/doi.org\/10.1007\/s00066-019-01446-5","journal-title":"Strahlenther Onkol"},{"issue":"28","key":"1538_CR22","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1200\/JCO.2005.04.031","volume":"23","author":"P Koch","year":"2005","unstructured":"Koch\u00a0P, Probst\u00a0A, Berdel\u00a0WE et\u00a0al (2005) Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02\/96). J\u00a0Clin Oncol 23(28):7050\u20137059. https:\/\/doi.org\/10.1200\/JCO.2005.04.031","journal-title":"J Clin Oncol"},{"issue":"4","key":"1538_CR23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0360-3016(99)00475-7","volume":"46","author":"NA Willich","year":"2000","unstructured":"Willich\u00a0NA, Reinartz\u00a0G, Horst\u00a0EJ et\u00a0al (2000) Operative and conservative management of primary gastric lymphoma: interim results of a\u00a0German multicenter study. Int J Radiat Oncol Biol Phys 46(4):895\u2013901","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1538_CR24","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/annonc\/mds623","volume":"24","author":"A Wirth","year":"2013","unstructured":"Wirth\u00a0A, Gospodarowicz\u00a0M, Aleman\u00a0BMP et al (2013) Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a\u00a0retrospective, multi-centre, International Extranodal Lymphoma Study Group study. Ann Oncol 24(5):1344\u20131351. https:\/\/doi.org\/10.1093\/annonc\/mds623","journal-title":"Ann Oncol"},{"issue":"36","key":"1538_CR25","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.3748\/wjg.v19.i36.6062","volume":"19","author":"S-W Kim","year":"2013","unstructured":"Kim\u00a0S\u2011W, Lim\u00a0DH, Ahn\u00a0YC et al (2013) Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma. WJG 19(36):6062\u20136068. https:\/\/doi.org\/10.3748\/wjg.v19.i36.6062","journal-title":"WJG"},{"issue":"6","key":"1538_CR26","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1097\/HS9.0000000000000160","volume":"2","author":"K Herfarth","year":"2018","unstructured":"Herfarth\u00a0K, Borchmann\u00a0P, Schnaidt\u00a0S et al (2018) Rituximab with involved field irradiation for early-stage nodal follicular lymphoma. HemaSphere 2(6):e160. https:\/\/doi.org\/10.1097\/HS9.0000000000000160","journal-title":"HemaSphere"},{"issue":"9873","key":"1538_CR27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","volume":"381","author":"MJ Rummel","year":"2013","unstructured":"Rummel\u00a0MJ, Niederle\u00a0N, Maschmeyer\u00a0G et al (2013) Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 381(9873):1203\u20131210. https:\/\/doi.org\/10.1016\/S0140-6736(12)61763-2","journal-title":"Lancet"},{"issue":"4","key":"1538_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/bjh.15720","volume":"184","author":"BT Hill","year":"2019","unstructured":"Hill\u00a0BT, Nastoupil\u00a0L, Winter\u00a0AM et al (2019) Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma. Br J Haematol 184(4):524\u2013535. https:\/\/doi.org\/10.1111\/bjh.15720","journal-title":"Br J Haematol"},{"issue":"10","key":"1538_CR29","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1056\/NEJMoa1805104","volume":"379","author":"F Morschhauser","year":"2018","unstructured":"Morschhauser\u00a0F, Fowler\u00a0NH, Feugier\u00a0P et\u00a0al (2018) Rituximab plus lenalidomide in advanced untreated follicular lymphoma. N\u00a0Engl J Med 379(10):934\u2013947. https:\/\/doi.org\/10.1056\/NEJMoa1805104","journal-title":"N Engl J Med"},{"issue":"3","key":"1538_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1182\/blood-2018-04-843540","volume":"133","author":"JL Brady","year":"2019","unstructured":"Brady\u00a0JL, Binkley\u00a0MS, Hajj\u00a0C et al (2019) Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a\u00a0collaborative study by ILROG. Blood 133(3):237\u2013245. https:\/\/doi.org\/10.1182\/blood-2018-04-843540","journal-title":"Blood"},{"issue":"5","key":"1538_CR31","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S2352-3026(19)30026-2","volume":"6","author":"F Morschhauser","year":"2019","unstructured":"Morschhauser\u00a0F, Flinn\u00a0IW, Advani\u00a0R et al (2019) Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a\u00a0phase 2 randomised study (ROMULUS). Lancet Haematol 6(5):e254\u2013e265. https:\/\/doi.org\/10.1016\/S2352-3026(19)30026-2","journal-title":"Lancet Haematol"},{"issue":"26","key":"1538_CR32","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","volume":"377","author":"SS Neelapu","year":"2017","unstructured":"Neelapu\u00a0SS, Locke\u00a0FL, Bartlett\u00a0NL et al (2017) Axicabtagene ciloleucel CAR T\u2011cell therapy in refractory large B\u2011cell lymphoma. N\u00a0Engl J Med 377(26):2531\u20132544. https:\/\/doi.org\/10.1056\/NEJMoa1707447","journal-title":"N Engl J Med"},{"issue":"6","key":"1538_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1182\/bloodadvances.2017013698","volume":"2","author":"S Qi","year":"2018","unstructured":"Qi\u00a0S, Huang\u00a0MY, Yang\u00a0Y et al (2018) Uptake of 18Ffluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma. Blood Adv 2(6):649\u2013655. https:\/\/doi.org\/10.1182\/bloodadvances.2017013698","journal-title":"Blood Adv"},{"issue":"16","key":"1538_CR34","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1002\/cncr.25149","volume":"116","author":"TJ Pugh","year":"2010","unstructured":"Pugh\u00a0TJ, Ballonoff\u00a0A, Newman\u00a0F et al (2010) Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation a surveillance, epidemiology, and end results database analysis. Cancer 116(16):3843\u20133851. https:\/\/doi.org\/10.1002\/cncr.25149","journal-title":"Cancer"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01538-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:04:33Z","timestamp":1605312273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01538-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1538"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01538-2","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"1 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.\u00a0Elsayad, G.\u00a0Reinartz, M.\u00a0Oertel, S.\u00a0Rehn, J.\u00a0Eismann, S.\u00a0Scobioala, H.\u00a0Berssenbr\u00fcgge, N.\u00a0Eter, C.\u00a0Weishaupt, H.H.\u00a0Schmidt, B.\u00a0Friedrichs, I.\u00a0Gr\u00fcnewald, W.\u00a0Hartmann, G.\u00a0Lenz, E.\u00a0Wardelmann, N.\u00a0Willich, and H.T.\u00a0Eich declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}